ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
123.906,55
-0,32%
S&P 500
5.460,48
-0,41%
US Dollar vs BRL
5,5936
0,00%
Bitcoin
60.903,12
0,98%
Brent Oil
84,85
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Bradley Pharmaceuticals (BDY)

  7. Bradley Pharmaceuticals (BDY) Notícias

BDY

Bradley (BDY)

Bradley Pharmaceuticals
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:BDY
DataHoraFonteTítuloCódigoCompanhia
13/05/200809:18PR Newswire (US)Medimetriks Pharmaceuticals, Inc. Begins OperationsNYSE:BDYBradley Pharmaceuticals
21/02/200820:54PR Newswire (US)QED International Associates Announces Changes to the HealthShares(TM) Dermatology and Wound Care IndexNYSE:BDYBradley Pharmaceuticals
21/02/200820:00Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Current report filing (8-K)NYSE:BDYBradley Pharmaceuticals
21/02/200820:00Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Post-Effective Amendment to an S-8 filing (S-8 POS)NYSE:BDYBradley Pharmaceuticals
21/02/200819:55Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NYSE:BDYBradley Pharmaceuticals
21/02/200819:02Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Amended Termination of Registration of a Class of Security under Section 12(g) (15-12G/A)NYSE:BDYBradley Pharmaceuticals
14/02/200820:51PR Newswire (US)Standard & Poor's Announces Change to U.S. IndexNYSE:BDYBradley Pharmaceuticals
14/02/200814:36Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)NYSE:BDYBradley Pharmaceuticals
23/01/200820:20Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Amended tender offer statement by Issuer (SC TO-I/A)NYSE:BDYBradley Pharmaceuticals
17/01/200820:14Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NYSE:BDYBradley Pharmaceuticals
17/01/200820:07PR Newswire (US)Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger WitNYSE:BDYBradley Pharmaceuticals
17/01/200815:19Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Tender offer statement by Issuer (SC TO-I)NYSE:BDYBradley Pharmaceuticals
17/01/200815:12Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)NYSE:BDYBradley Pharmaceuticals
14/12/200710:45PR Newswire (US)Bradley Pharmaceuticals Launches Veregen(TM) (sinecatechins) Ointment, 15%NYSE:BDYBradley Pharmaceuticals
11/12/200709:01Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Proxy Statement - Merger or Acquistion (preliminary) (PREM14A)NYSE:BDYBradley Pharmaceuticals
26/11/200720:06Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (SC 13D/A)NYSE:BDYBradley Pharmaceuticals
26/11/200710:45PR Newswire (US)Bradley Pharmaceuticals Launches ROSULA(R) CLK(TM)NYSE:BDYBradley Pharmaceuticals
08/11/200719:51PR Newswire (US)Bradley Pharmaceuticals 2007 Third Quarter ResultsNYSE:BDYBradley Pharmaceuticals
08/11/200719:47Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Quarterly Report (10-Q)NYSE:BDYBradley Pharmaceuticals
30/10/200711:17PR Newswire (US)Nycomed Signs Definitive Agreement to Acquire Bradley Pharmaceuticals, Inc., Strengthening US Specialty BusinessNYSE:BDYBradley Pharmaceuticals
30/10/200710:00PR Newswire (US)Bradley Pharmaceuticals Announces Definitive Merger Agreement with Nycomed for $20 Per Share in CashNYSE:BDYBradley Pharmaceuticals
28/09/200708:45PR Newswire (US)Bradley Pharmaceuticals to Feature Elestrin(TM) at North American Menopause Society Annual MeetingNYSE:BDYBradley Pharmaceuticals
10/08/200701:36PR Newswire (US)Bradley Pharmaceuticals Special Committee Receives Non-binding Preliminary BidsNYSE:BDYBradley Pharmaceuticals
09/08/200719:10PR Newswire (US)Bradley Pharmaceuticals 2007 Second Quarter ResultsNYSE:BDYBradley Pharmaceuticals
31/07/200708:45PR Newswire (US)Bradley Pharmaceuticals to Report Second Quarter 2007 Financial Results and Schedules Conference CallNYSE:BDYBradley Pharmaceuticals
28/06/200709:45PR Newswire (US)Bradley Pharmaceuticals Launches Kerol(TM) Topical Suspension and ROSULA(R) Clarifying Wash(TM)NYSE:BDYBradley Pharmaceuticals
21/06/200709:00Business WireNew Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aNYSE:BDYBradley Pharmaceuticals
20/06/200712:30PR Newswire (US)New, Effective Low Dose Estrogen Therapy Introduced to National MediaNYSE:BDYBradley Pharmaceuticals
15/06/200709:45PR Newswire (US)Bradley Pharmaceuticals Launches Peranex(TM) HC CreamNYSE:BDYBradley Pharmaceuticals
13/06/200709:45PR Newswire (US)Bradley Pharmaceuticals Announces Launch of Elestrin(TM)NYSE:BDYBradley Pharmaceuticals
 Apresentando as notícias mais relevantes sobre:NYSE:BDY

Seu Histórico Recente

TSXV
ATF
TG
A19W9P
Legrand
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados